Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]
News [3524]
Articles [160]
Editorials [3]
Conferences [127]
elearning [18]

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France
Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )
8 Sep 2015

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany
Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
8 Sep 2015

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy

Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors

Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015

A laboratory model of the hypoxic tumour microenvironment

Dr Giles Best - Royal North Shore Hospital, Sydney, Australia
A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )
8 Sep 2015

Will chemotherapy remain the cornerstone of CLL management?

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany
Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
8 Sep 2015

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA
Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )
7 Sep 2015

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA
History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )
7 Sep 2015

Human B-cell receptor structure and function in CLL

Prof Freda Stevenson - University of Southampton, Southampton, UK
Human B-cell receptor structure and function in CLL ( Prof Freda Stevenson - University of Southampton, Southampton, UK )
7 Sep 2015

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA
Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )
7 Sep 2015

The role of CLL cells, T-cells and macrophages and their effects on the tumour microenvironment

Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands
The role of CLL cells, T-cells and macrophages and their effects on the tumour microenvironment ( Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands )
7 Sep 2015

Understanding the intricacies of platelet activation and inhibition

Prof Carlo Patrono – Catholic University School of Medicine, Rome, Italy
Understanding the intricacies of platelet activation and inhibition ( Prof Carlo Patrono – Catholic University School of Medicine, Rome, Italy )
2 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation